# LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ly3298176-a-novel-dual-gip-and-glp-1-receptor-agonist-for-the-treatment-of-type/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tamer Coşkun,Kyle W. Sloop,Corina Loghin,Jorge Alsina‐Fernandez,Shweta Urva,Krister Bokvist,Xuewei Cui,Daniel A. Briere,Over Cabrera,William C. Roell,Uma Kuchibhotla,Julie S. Moyers,Charles Benson,Ruth E. Gimeno,David A. D’Alessio,Axel Haupt |
| Citations | 847 |
| DOI | 10.1016/j.molmet.2018.09.009 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.sciencedirect.com/science/article/pii/S2212877818309001/pdf |
| OpenAlex ID | https://openalex.org/W2895135221 |
| PMID | 30473097 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Axel Haupt](https://scholariq.org/researchers/axel-haupt/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.